Augmented Reality Rehabilitation for Acquired Brain Injury
Trial Summary
What is the purpose of this trial?
Factors related to successful rehabilitation in acquired brain injury (ABI) are often directly related to adherence; for instance, dosage, frequency, and intensity can burden the patient regarding time and motivational factors. Regarding salience, patients may lose interest or find a traditional intervention boring after a few sessions. It is well documented that nonadherence not only impacts rehabilitation for patients but can also further prolong treatment, and increase hospital and clinician costs, in addition to a higher prevalence of future comorbidities. Additionally, the same factors that are related to can impact adherence are also related to neuroplasticity. Therefore, strategies that improve patient adherence can significantly help optimize patient care and treatment outcomes for those with ABI. The gamification of rehabilitation therapies using augmented reality (AR) may help promote adherence. Gamification of rehabilitation therapy can make mass practice required in rehabilitation therapies seemingly fun and more personally engaging for the patient. Additionally, the experience achieved through AR can further promote salience and be customizable to individual patient requirements. As AR systems are now highly portable, cost-effective, and relatively simple to utilize, they can provide an excellent opportunity to provide more engaging rehabilitation approaches compared to standard care alone. AR gamification of rehabilitation may increase adherence by shifting patients' perspectives of therapy as tedious, boring, or a hassle, to a fun and engaging game that ultimately helps their recovery processes. The GlenXRose AR-delivered ABI program (developed by the Cognitive Projections Lab, University of Alberta) has been created in collaboration with the Glenrose Rehabilitation Hospital with the overall goal of increasing patient adherence, treatment outcomes, and satisfaction with ABI rehabilitation therapy. The proposed studies are to investigate the feasibility of implementing this technology alongside routine clinical care, obtaining clinician feedback, examining associated financial costs, and continuing to examine the effect of the GlenXRose AR ABI-therapies on patient adherence and clinical outcomes, compared to traditional clinical care alone.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment GlenXRose Augmented Reality Acquired Brain Injury Therapies?
Research suggests that augmented reality (AR) and virtual reality (VR) can help improve rehabilitation outcomes for people with acquired brain injuries by enhancing physical therapy, improving motor function, and reducing the need for professional supervision. For example, a case study showed that a man with a brain injury improved his walking and leg movement after using VR-based therapy.12345
Is augmented reality rehabilitation safe for people with acquired brain injury?
Research on immersive virtual reality, which is similar to augmented reality, shows it is generally safe for brain injury rehabilitation, with no serious adverse events reported. Some patients experienced mild dizziness, but overall satisfaction was moderate, and the treatment was considered safe.12467
How is the GlenXRose Augmented Reality Acquired Brain Injury Therapies treatment different from other treatments for acquired brain injury?
The GlenXRose Augmented Reality Acquired Brain Injury Therapies treatment is unique because it uses augmented reality (AR) technology to enhance rehabilitation, potentially reducing the need for professional supervision and speeding up recovery. This approach integrates advanced digital technologies to provide multisensory experiences that can improve cognitive and motor skills, making it a novel option compared to traditional rehabilitation methods.12348
Research Team
Jim Raso, MASc
Principal Investigator
Glenrose Foundation
Eligibility Criteria
This trial is for adults at the Glenrose Rehabilitation Hospital in Edmonton, Canada with mild to moderate acquired brain injury. Participants must speak English and have enough upper-limb strength and coordination to use an AR headset. It's not for children, those with severe brain injuries or cognitive disorders, severe aphasia, communication disorders that affect understanding verbal commands, previous neurological/psychiatric conditions, substance misuse issues, or impairments limiting interaction with AR.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the GlenXRose augmented reality therapies alongside standard clinical care for acquired brain injury rehabilitation
Follow-up
Participants are monitored for adherence, cognitive functioning, and motor coordination after treatment
Treatment Details
Interventions
- GlenXRose Augmented Reality Acquired Brian Injury Therapies
GlenXRose Augmented Reality Acquired Brian Injury Therapies is already approved in Canada for the following indications:
- Acquired Brain Injury Rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Alberta Health services
Collaborator
Mitacs
Industry Sponsor